Americans are snacking less, Novo bets $1B on new drug, Rybelsus' cardiovascular impacts are mixed, Danone adapts marketing strategy for the GLP-1 era, and more!
The Gut Punch Weekly #14
Americans are snacking less, Novo bets $1B on new drug, Rybelsus' cardiovascular impacts are mixed, Danone adapts marketing strategy for the GLP-1 era, and more!